BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11173194)

  • 1. Rapid discrimination between BRO beta-lactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis.
    du Plessis M
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):65-7. PubMed ID: 11173194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.
    Köseoglu O; Ergin A; Hascelik G
    Scand J Infect Dis; 2004; 36(6-7):431-4. PubMed ID: 15307563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases.
    Steingrube VA; Wallace RJ; Beaulieu D
    J Antimicrob Chemother; 1993 Feb; 31(2):237-44. PubMed ID: 8463169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
    Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
    J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan.
    Ikeda F; Yokota Y; Mine Y; Yamada T
    Chemotherapy; 1993; 39(2):88-95. PubMed ID: 8458251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
    Levy F; Walker ES
    J Antimicrob Chemother; 2004 Feb; 53(2):371-4. PubMed ID: 14729761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
    Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
    Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.
    Eliasson I; Kamme C; Vang M; Waley SG
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):313-21. PubMed ID: 1396750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [beta-Lactamases of Branhamella catarrhalis and their phenotypic implications].
    Chaïbi EB; Mugnier P; Kitzis MD; Goldstein FW; Acar JF
    Res Microbiol; 1995; 146(9):761-71. PubMed ID: 8584798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.
    Bootsma HJ; van Dijk H; Vauterin P; Verhoef J; Mooi FR
    Mol Microbiol; 2000 Apr; 36(1):93-104. PubMed ID: 10760166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K; Chang BJ; Mee BJ; Riley TV
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital.
    Yamada K; Arai K; Saito R
    J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains.
    Kadry AA; Fouda SI; Elkhizzi NA; Shibl AM
    Int J Antimicrob Agents; 2003 Nov; 22(5):532-6. PubMed ID: 14602374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
    J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
    Christensen JJ; Keiding J; Bruun B
    APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
    Ejlertsen T; Skov R
    APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
    Wallace RJ; Steingrube VA; Nash DR; Hollis DG; Flanagan C; Brown BA; Labidi A; Weaver RE
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern.
    Fung CP; Yeo SF; Livermore DM
    J Antimicrob Chemother; 1994 Feb; 33(2):215-22. PubMed ID: 8182002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.